A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

PHASE4CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Subjects
Interventions
BIOLOGICAL

7-pneumococcal conjugate vaccine (7vPnC)

0.5 mL per dose, 4 doses

BIOLOGICAL

diphtheria, tetanus, and acellular pertussis vaccine (DTaP)

0.5 mL per dose, 4 doses

BIOLOGICAL

DTaP

0.5 mL per dose, 4 doses

Trial Locations (18)

Unknown

Tsubaki Children's Clinic, Chiba

Sotobo Children's Clinic, Isumi

Matsuyama Red Cross Hospital, Matsuyama

Kiyomatsu Childrens Clinic, Fukuoka

National Hospital Organization Fukuoka National Hospital, Fukuoka

Shindo Children's Clinic, Fukuoka

Takasaki Clinic Pedatrics and Child Health, Fukuoka

Yamashita Pediatrics Clinic, Itoshima

Yokoyama Children's Clinic, Kasuga

Furuta Children's Clinic, Sapporo

Tenshi Hospital, Sapporo

Watanabe Pediatric Allergy Clinic, Sapporo

Yamanaka Tatsuru Pediatrics, Sapporo

Matsuda Pediatrics Clinic, Kuwana

Kawasaki Medical School, Department of Pediatrics, Kurashiki

Momotaro Clinic, Okayama

Hug Hug Kids Clinic, Toyonaka

Shibuya Clinic, Kumagaya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY